Skip to content

Acupuncture's effect on blood pressure in Prehypertensive and stage I Hypertensive patients with low cardiovascular risk

Acupuncture's effect on blood pressure levels in Prehypertensive and stage I Hypertensive patients with low cardiovascular risk

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9qnxb9z
Enrollment
Unknown
Registered
2024-02-29
Start date
2023-10-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

This is a randomized clinical trial that will consist of two groups: intervention group and control group, with 20 patients each one.Participants will be randomized using the website www.randomization
H02.004

Sponsors

Universidade Federal de Goiás
Lead Sponsor
Universidade Federal de Goiás
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients aged 18 years or over; prehypertensive or stage 1 hypertensive patients at low cardiovascular risk; not taking antihypertensive medication; evaluated at the screening consultation

Exclusion criteria

Exclusion criteria: Patients with stage 2 or 3 arterial hypertension or stage 1 arterial hypertension of moderate or high cardiovascular risk; using any medication with a known influence on blood pressure; diabetics; nephropaths; patients with a history of coronary artery and/or cerebrovascular disease; heart failure and/or thyroid diseases; with any condition that impairs the afferent and efferent conduction of nervous stimulation; severe blood dyscrasias; use of anticoagulants; skin lesions and/or any condition that makes access to the described acupoints impossible; pregnant and lactating women; with not controlled psychiatric illnesses ; who have received antihypertensive drug treatment in the last 6 months or who have already undergone acupuncture at some point in their lives

Design outcomes

Primary

MeasureTime frame
It is expected to find a reduction of 5 mmHg in systolic blood pressure in the intervention group

Secondary

MeasureTime frame
It is expected to find improvement in quality of life assessed by the EQ-5D questionnaire in the intervention group

Countries

Brazil

Contacts

Public ContactAmanda Bitencourt

Universidade Federal de Goiás

dra.amandabitencourt@gmail.com+55623521-1000

Outcome results

None listed

Source: REBEC (via WHO ICTRP)